Author:
Nitzan Uri,Bekerman Tal,Becker Gideon,Lichtenberg Pesach,Lev-Ran Shaul,Walter Garry,Maoz Hagai,Bloch Yuval
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference22 articles.
1. Nielsen M, Gøtzsche P. An analysis of psychotropic drug sales. Increasing sales of selective serotonin reuptake inhibitors are closely related to number of products. Int J Risk Saf Med. 2011;23:125–32.
2. Hirschfeld RM. The epidemiology of depression and the evolution of treatment. J Clin Psychiatry. 2012;73(1):5–9.
3. Jeffrey AK, Ross M, William W, Bradley CM, Hirohisa I, Gary T, et al. Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort. Clin Ther. 2002;24:3724.
4. Sclar DA, Robison LM, Skaer TL. Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States. Int Clin Psychopharmacol. 2008;23:106–9.
5. Garfield S, Francis S-A, Smith FJ. Building concordant relationships with patients starting antidepressants medication. Patient Educ Couns. 2004;55:241–6.